Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-02

FDA Approved: AZSTARYS — Original Application (Corium, LLC.)

View source ↗

Summary

The FDA approved AZSTARYS, a once-daily ADHD medication containing serdexmethylphenidate and dexmethylphenidate, from Corium, LLC, under an original NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azstarys (serdexmethylphenidate/dexmethylphenidate)

Snippet

ORIG AP for AZSTARYS (SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE)